Oliviero Riggio
Oliviero Riggio
Unknown affiliation
Verified email at
Cited by
Cited by
ESPEN guidelines on enteral nutrition: liver disease
M Plauth, E Cabre, O Riggio, M Assis-Camilo, M Pirlich, J Kondrup, ...
Clinical nutrition 25 (2), 285-294, 2006
Incidence and natural history of small esophageal varices in cirrhotic patients
M Merli, G Nicolini, S Angeloni, V Rinaldi, A De Santis, C Merkel, AF Attili, ...
Journal of hepatology 38 (3), 266-272, 2003
Does malnutrition affect survival in cirrhosis?
M Merli, O Riggio, L Dally
Hepatology 23 (5), 1041-1046, 1996
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
P Caraceni, O Riggio, P Angeli, C Alessandria, S Neri, FG Foschi, ...
The Lancet 391 (10138), 2417-2429, 2018
Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites
F Salerno, M Merli, O Riggio, M Cazzaniga, V Valeriano, M Pozzi, ...
Hepatology 40 (3), 629-635, 2004
Cirrhotic patients are at risk for health care–associated bacterial infections
M Merli, C Lucidi, V Giannelli, M Giusto, O Riggio, M Falcone, L Ridola, ...
Clinical Gastroenterology and Hepatology 8 (11), 979-985. e1, 2010
MELD score is better than Child–Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt
F Salerno, M Merli, M Cazzaniga, V Valeriano, P Rossi, A Lovaria, ...
Journal of hepatology 36 (4), 494-500, 2002
Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts
O Riggio, S Angeloni, FM Salvatori, A De Santis, F Cerini, A Farcomeni, ...
Official journal of the American College of Gastroenterology| ACG 103 (11 …, 2008
Nutritional status: its influence on the outcome of patients undergoing liver transplantation
M Merli, M Giusto, F Gentili, G Novelli, G Ferretti, O Riggio, SG Corradini, ...
Liver International 30 (2), 208-214, 2010
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
J Trebicka, J Fernandez, M Papp, P Caraceni, W Laleman, C Gambino, ...
Journal of hepatology 73 (4), 842-854, 2020
Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
O Riggio, S Nardelli, F Moscucci, C Pasquale, L Ridola, M Merli
Clinics in liver disease 16 (1), 133-146, 2012
Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study
M Merli, M Giusto, C Lucidi, V Giannelli, I Pentassuglio, V Di Gregorio, ...
Metabolic brain disease 28, 281-284, 2013
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study
O Riggio, A Masini, C Efrati, F Nicolao, S Angeloni, FM Salvatori, M Bezzi, ...
Journal of hepatology 42 (5), 674-679, 2005
Antithrombotic treatment with direct‐acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis
A De Gottardi, J Trebicka, C Klinger, A Plessier, S Seijo, B Terziroli, ...
Liver International 37 (5), 694-699, 2017
High prevalence of spontaneous portal‐systemic shunts in persistent hepatic encephalopathy: a case‐control study
O Riggio, C Efrati, C Catalano, F Pediconi, O Mecarelli, N Accornero, ...
Hepatology 42 (5), 1158-1165, 2005
Modification of cardiac function in cirrhotic patients with and without ascites
V Valeriano, S Funaro, R Lionetti, O Riggio, G Pulcinelli, P Fiore, A Masini, ...
The American journal of gastroenterology 95 (11), 3200-3205, 2000
Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial
M Merli, F Salerno, O Riggio, R de Franchis, F Fiaccadori, P Meddi, ...
Hepatology 27 (1), 48-53, 1998
Polytetrafluoroethylene-covered nitinol stent-graft for transjugular intrahepatic portosystemic shunt creation: 3-year experience
P Rossi, FM Salvatori, F Fanelli, M Bezzi, M Rossi, G Marcelli, D Pepino, ...
Radiology 231 (3), 820-830, 2004
Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement
S Nardelli, B Lattanzi, S Torrisi, F Greco, A Farcomeni, S Gioia, M Merli, ...
Clinical Gastroenterology and Hepatology 15 (6), 934-936, 2017
Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice
S Angeloni, C Leboffe, A Parente, M Venditti, A Giordano, M Merli, ...
World journal of gastroenterology: WJG 14 (17), 2757, 2008
The system can't perform the operation now. Try again later.
Articles 1–20